<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00573053</url>
  </required_header>
  <id_info>
    <org_study_id>B2007:157</org_study_id>
    <nct_id>NCT00573053</nct_id>
  </id_info>
  <brief_title>Effects of Targeting Lower Arterial Oxygen Saturations on the Development of Control of Breathing in Very Preterm Infants</brief_title>
  <official_title>Effects of Targeting Lower Arterial Oxygen Saturations on the Development of Control of Breathing in Very Preterm Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether targeting lower arterial oxygen saturations from the day of birth alters
      the early (first 3 months) postnatal development of the control of ventilation and the
      hypercapnic and hyperoxic responses in very preterm infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To measure the effects of baseline oxygenation in extremely low birth weight preterm infants
      on:

      i) The early (first 5 breaths) and late or steady state (3-5 minutes) ventilatory response to
      CO2 ii) The immediate (&lt; 1 minute) ventilatory response to hyperoxia iii) The PCO2 apneic
      threshold iv) The breathing pattern during quiet and REM sleep v) The morphology of periodic
      breathing cycles vi) The incidence and morphology of sighs
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effects of targeting lower arterial oxygen saturations on the development of control of breathing in very preterm infants</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To measure the effects of baseline oxygenation in extremely low birth weight preterm infants on the ventilatory response to CO2 and O2, the PCO2 apneic threshold, and the baseline breathing pattern</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">26</enrollment>
  <condition>Development of Control of Breathing</condition>
  <arm_group>
    <arm_group_label>High</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Arterial oxygen saturations in the range of 91-95%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arterial oxygen saturations in the range of 85-89%</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oxygen saturation range</intervention_name>
    <description>Maintain functional oxygen saturation range between 91 and 95%</description>
    <arm_group_label>High</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oxygen saturation range</intervention_name>
    <description>Maintain functional arterial oxygen saturations in the range of 85- 89%</description>
    <arm_group_label>Low</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gestational age 23 0/7 - 27 6/7 weeks

          -  Enrolled in the COT trial at the Health Sciences Centre and the St. Boniface General
             Hospital in Winnipeg

          -  Postnatal age between 21 days and 70 days

          -  Informed written consent obtained from at least one of the parents.

        Exclusion Criteria:

          -  Need for mechanical ventilation, NCPAP or O2

          -  Sepsis or other known causes of apnea.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>70 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruben E Alvaro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Boniface General Hospital</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R2H 2A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Science Centre</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 0L8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2007</study_first_submitted>
  <study_first_submitted_qc>December 12, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2007</study_first_posted>
  <last_update_submitted>April 18, 2011</last_update_submitted>
  <last_update_submitted_qc>April 18, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 19, 2011</last_update_posted>
  <responsible_party>
    <name_title>Ruben E. Alvaro, Associate Professor of Pediatrics, University of Manitoba</name_title>
    <organization>University of Manitoba</organization>
  </responsible_party>
  <keyword>hypercapneic response</keyword>
  <keyword>hyperoxic response</keyword>
  <keyword>breathing pattern</keyword>
  <keyword>periodic breathing</keyword>
  <keyword>sighs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

